Doxorubicin Hydrochloride Injection, Suspension, Liposomal
Product Images NDC 70748-339

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 70748-339). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxorubicin Hydrochloride (1a930cb7 5363 4229 9f39 53edc07a43d6 01)

Chemical structure of doxorubicin hydrochloride, depicting its molecular arrangement with functional groups and the hydrochloride component.*

FDA Label Image

Mpeg-dspe (1a930cb7 5363 4229 9f39 53edc07a43d6 02)

Chemical structure diagram of doxorubicin hydrochloride showing lipid components with fatty acid chains and a polyethylene glycol segment indicated by 'n = ca. 45'. The structure includes phosphate groups and sodium ion notation, consistent with a liposomal formulation.*

FDA Label Image

Hspc (1a930cb7 5363 4229 9f39 53edc07a43d6 03)

Chemical structure of the active ingredient doxorubicin hydrochloride, as depicted in the molecular diagram showing bonds and atomic groups for the liposomal injection formulation.*

FDA Label Image

Pegylated Liposome (1a930cb7 5363 4229 9f39 53edc07a43d6 04)

An illustration depicting the structure of a liposomal doxorubicin hydrochloride particle. It shows an aqueous core containing entrapped doxorubicin HCl, surrounded by a liposomal bilayer, and an outer MPEG-DSPE coating layer.*

FDA Label Image

Figure 1 (1a930cb7 5363 4229 9f39 53edc07a43d6 05)

A Kaplan-Meier survival curve showing the percent of subjects progression-free over time in months. The graph compares two groups: Doxorubicin HCl + Bortezomib versus Bortezomib alone, with the combined treatment group showing higher progression-free survival. The chart includes a p-value, hazard ratio with confidence interval, and censored data points marked.*

FDA Label Image

Vial Label (1a930cb7 5363 4229 9f39 53edc07a43d6 06)

Label for DOXORUBICIN HYDROCHLORIDE Liposome Injection, 20 mg/10 mL (2 mg/mL) in a 10 mL single-dose vial by Lupin Pharmaceuticals, Inc. The label indicates intravenous use, storage refrigeration (2° to 8°C), and contains warnings about liposomal formulation and proper dilution. Manufactured by ForDoz Pharma Corporation.*

FDA Label Image

Carton Label (1a930cb7 5363 4229 9f39 53edc07a43d6 07)

Packaging label for DOXOrubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) single-dose vial by Lupin Pharmaceuticals, Inc. The label highlights that it is a liposomal formulation and not a substitute for doxorubicin hydrochloride. It includes dosage form, strength, directions for refrigeration, and manufacturer and distributor information. The label also includes regulatory and barcode details.*

FDA Label Image

Vial Label (1a930cb7 5363 4229 9f39 53edc07a43d6 08)

DOXORUBicin Hydrochloride Liposome Injection 50 mg/25 mL (2 mg/mL) label for intravenous use. The label is for a 25 mL single-dose vial, manufactured by ForDoz Pharma Corporation and distributed by Lupin Pharmaceuticals, Inc. Storage instructions indicate refrigeration at 2° to 8°C and the formulation is cytotoxic with specific handling guidelines.*

FDA Label Image

Carton Label (1a930cb7 5363 4229 9f39 53edc07a43d6 09)

Packaging label for DOXOrubicin Hydrochloride Liposome Injection, 50 mg/25 mL (2 mg/mL), an intravenous liposomal suspension. Label includes dosage form, strength, single-dose vial volume, manufacturer Lupin Pharmaceuticals, Inc., storage instructions, and warnings that it is a cytotoxic drug and not a substitute for doxorubicin hydrochloride. The label also provides detailed ingredient and formulation information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.